Disaggro (Zalunfiban) for Pre-hospital Treatment of STEMI: Phase 3 Results to Be Presented at AHA 2025
CeleCor Therapeutics reposted from Dirk Sibbing on LinkedIn:
”Excited to see the news about our Phase 3 CeleBrate trial of Disaggro™ (zalunfiban) being picked up – appreciate the share Dirk Sibbing.
The full study results will be presented as part of the Late-Breaking Science Sessions at the American Heart Association Scientific Sessions (AHA 2025) in New Orleans on November 10, 2025.
Stay tuned!”
”A new drug on the horizon for pre-hospital treatment of STEMI patients
Subcutaneous GPIIb/IIIa – Dissaggpro
Rapid onset and fast offset of antiplatelet action
Phase 3 Study (CeleBrate) of Novel Anti-Platelet Drug for Heart Attack Reports Positive Topline Results as announced by CeleCor Therapeutics
This, for sure, will bring new aspects into the discussions on pretreatment (antiplatelet) for STEMI patients…
Still we are loosing too many patients pre-hospital and before we see them in the cath lab…
Results will be presented as LBCT at AHA 2025 in New Orleans”
Read the full article here.
Stay updated on the emerging with Hemostasis Today.
-
Apr 3, 2026, 13:21Strengthening Care for Bleeding Disorders in Latin America – WFH
-
Apr 3, 2026, 11:44Shiny K. Kajal: Transfusion Decisions are Still Often Reduced to a Single Number in Daily Practice
-
Apr 3, 2026, 05:59Nathan Connell: How the 2021 VWD Guidelines Are Actually Changing Real – World Practice
-
Apr 3, 2026, 05:28Tareq Abadl: How Iron Profile Reveals Hidden Insights about Blood Health and Iron Balance
-
Apr 3, 2026, 04:49Niraj Sharma: Breaking News Special Edition, CHAMPION-AF, CLOSURE-AF, PRAGUE-17, and Why LAAC Still Does Not Dethrone Contemporary Anticoagulation
-
Apr 2, 2026, 18:32Niyas Khalid: A Rare Case of Venous Ischemic Pancreatitis Redefining Diagnosis
-
Apr 2, 2026, 18:16Saravanan Subramaniam: How Extracellular Histones Act as Key Drivers of Thromboinflammation
-
Apr 2, 2026, 18:06Rob Molhoek Brings Invaluable Insights on Stroke Awareness and Care Improvements – Stroke Foundation
-
Apr 2, 2026, 17:21Paul Bolaji: Phase 2 of the Nigeria National Stroke Registry Is Now Live